OncBioMune Appoints Dr. Mick Ruxin as President & CEO and Jeffrey Busch as Chairman of the Board

Author's Avatar
Jun 10, 2020
Article's Main Image

GOLDEN, CO / ACCESSWIRE / June 10, 2020 / OncBioMune Pharmaceuticals, Inc. (OTC PINK:OBMP) ("OncBioMune") today announced the appointment of Mick Ruxin, M.D. as President & CEO and Mr. Jeffrey Busch as Chairman of the Board upon closing of its previously announced asset purchase agreement (Link: https://www.accesswire.com/593012/OncBioMune-Announces-Closing-of-Asset-Purchase-Agreement-with-Avant-Diagnostics).